Community-based mpox responses and monitoring among Two-Spirit, Gay, Bisexual, and Queer Men and Non-Binary People Across Canada
Dr. Nathan Lachowsky | January 24, 2024 12-1pm ET
Learning objectives: (1) Engage with community-based research principles as a framework to approach how to conduct studies with Two-Spirit, Gay, Bisexual, and Queer Men and Non-Binary people. (2) Understand community-based responses to mpox among Two-Spirit, Gay, Bisexual, and Queer Men and Non-Binary People Across Canada. (3) Describe the ways in which social determinants of health drive health inequities related to mpox awareness, diagnosis, and vaccination among Two-Spirit, Gay, Bisexual, and Queer Men and Non-Binary People across Canada.
ABOUT THE SPEAKER: Dr. Nathan Lachowsky, PhD
Nathan Lachowsky (he, him, his) is an uninvited settler researcher of Ukrainian and English descent. He serves as Research Director of the non-profit Community Based Research Centre, as well as the Acting Director of the Institute for Aging and Lifelong Health at the University of Victoria. Championing community-based approaches, he has conducted population health HIV and STBBI research with sexual and gender minoritized communities – particularly Indigenous Two-Spirit and Lesbian, Gay, Bisexual, Transgender, and Queer people across Canada and Aotearoa New Zealand. He conducts interdisciplinary research within a social justice framework in order to achieve health equity for marginalized communities.
ABOUT THE MODERATOR: Dr. Caroline Cameron, PhD
Dr. Caroline Cameron is a Professor in the Department of Biochemistry and Microbiology at the University of Victoria in Victoria BC, Canada, and an Affiliate Professor in the Department of Medicine, Division of Allergy and Infectious Diseases at the University of Washington in Seattle, Washington, USA. She is Past-President of the International Society for Sexually Transmitted Diseases Research (ISSTDR) and chaired the 2019 STI & HIV World Congress held in Vancouver, BC, Canada. Caroline’s research program focuses upon the identification and characterization of molecules that are central to the pathogenesis of Treponema pallidum subsp. pallidum, causative agent of syphilis, with the ultimate goal of translating these research discoveries into vaccine candidates and novel diagnostic assays.
